Merrimack was founded in 2000 and went public in 2007. Merrimack's headquarters are located in Cambridge, MA. Merrimack is focused on discovering, developing and preparing to commercialize innovative medicines paired with diagnostics for the treatment of cancer. In 2015, Merrimack refocused its strategy and operations exclusively on the research, development and commercialization of oncology medicines.
https://en.wikipedia.org/wiki/Merrimack_Pharmaceuticals
https://in.investing.com/equities/merrimack-pharmaceuticals-inc
https://finance.yahoo.com/quote/MACK/profile?p=MACK
https://www.comparably.com/companies/merrimack-pharmaceuticals/mission
https://www.crunchbase.com/organization/merrimack-pharmaceuticals
